{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T17:45:05Z","timestamp":1787939105182,"version":"build-2784847793"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["journalofpsychiatricresearch.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Psychiatric Research"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/j.jpsychires.2017.02.008","type":"journal-article","created":{"date-parts":[[2017,2,9]],"date-time":"2017-02-09T16:16:17Z","timestamp":1486656977000},"page":"60-66","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Drug-induced panic attacks: Analysis of cases registered in the French pharmacovigilance database"],"prefix":"10.1016","volume":"90","author":[{"given":"Delphine","family":"Abadie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4123-7034","authenticated-orcid":false,"given":"Ana\u00efs","family":"Essilini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8436-7584","authenticated-orcid":false,"given":"Virginie","family":"Fulda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aurore","family":"Gouraud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e9lissa","family":"Y\u00e9l\u00e9h\u00e9-Okouma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00eblle","family":"Micallef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Montastruc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean Louis","family":"Montastruc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpsychires.2017.02.008_bib1","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0022-3956(95)00035-6","article-title":"Hypothalamic-pituitary-adrenal axis activity in panic disorder: effects of alprazolam on 24 h secretion of adrenocorticotropin and cortisol","volume":"30","author":"Abelson","year":"1996","journal-title":"J.\u00a0Psychiatr. Res."},{"key":"10.1016\/j.jpsychires.2017.02.008_bib2","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1002\/da.20220","article-title":"HPA axis activity in patients with panic disorder: review and synthesis of four studies","volume":"24","author":"Abelson","year":"2007","journal-title":"Depress. Anxiety"},{"key":"10.1016\/j.jpsychires.2017.02.008_bib3","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.biopsych.2009.03.012","article-title":"The serotonin-1A receptor in anxiety disorders","volume":"66","author":"Akimova","year":"2009","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jpsychires.2017.02.008_bib4","series-title":"DSM-5","author":"American Psychiatric Association","year":"2016"},{"key":"10.1016\/j.jpsychires.2017.02.008_bib5","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1017\/S1461145701002632","article-title":"Anxiety-like effects induced by acute fluoxetine, sertraline or m-CPP treatment are reversed by pretreatment with the 5-HT2C receptor antagonist SB-242084 but not the 5-HT1A receptor antagonist WAY-100635","volume":"4","author":"Bagdy","year":"2001","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.jpsychires.2017.02.008_bib6","doi-asserted-by":"crossref","first-page":"3221","DOI":"10.1038\/npp.2008.52","article-title":"Acute 5-HT reuptake blockade potentiates human amygdala reactivity","volume":"33","author":"Bigos","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jpsychires.2017.02.008_bib7","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1176\/appi.ajp.162.5.983","article-title":"Functional brain imaging alterations in acne patients treated with isotretinoin","volume":"162","author":"Bremner","year":"2005","journal-title":"AJP"},{"key":"10.1016\/j.jpsychires.2017.02.008_bib8","doi-asserted-by":"crossref","first-page":"37","DOI":"10.4088\/JCP.10r05993","article-title":"Retinoic acid and affective disorders: the evidence for an association","volume":"73","author":"Bremner","year":"2012","journal-title":"J.\u00a0Clin. Psychiatry"},{"key":"10.1016\/j.jpsychires.2017.02.008_bib9","doi-asserted-by":"crossref","first-page":"109","DOI":"10.2165\/00002018-199920020-00002","article-title":"The medical dictionary for regulatory activities (MedDRA)","volume":"20","author":"Brown","year":"1999","journal-title":"Drug. Saf."},{"key":"10.1016\/j.jpsychires.2017.02.008_bib10","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.biopsych.2007.09.014","article-title":"Amygdala volume in patients receiving chronic corticosteroid therapy","volume":"63","author":"Brown","year":"2008","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jpsychires.2017.02.008_bib11","series-title":"Goodman and Gillman's. The Pharmacological Basis of Therapeutics","author":"Brunton","year":"2011"},{"key":"10.1016\/j.jpsychires.2017.02.008_bib12","doi-asserted-by":"crossref","first-page":"319","DOI":"10.2165\/11588460-000000000-00000","article-title":"Patient experiences of serious adverse drug reactions and their attitudes to medicines: a qualitative study of survivors of Stevens-Johnson syndrome and toxic epidermal necrolysis in the UK","volume":"34","author":"Butt","year":"2011","journal-title":"Drug. Saf."},{"key":"10.1016\/j.jpsychires.2017.02.008_bib13","first-page":"189","article-title":"Serotonin related functions in panic-anxiety: a critical overview","volume":"6","author":"Coplan","year":"1992","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jpsychires.2017.02.008_bib14","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/S0022-3565(24)39009-3","article-title":"Stimulus-dependent modulation of [(3)H]norepinephrine release from rat neocortical slices by gabapentin and pregabalin","volume":"295","author":"Dooley","year":"2000","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.jpsychires.2017.02.008_bib15","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00702-012-0811-1","article-title":"Revise the revised? New dimensions of the neuroanatomical hypothesis of panic disorder","volume":"120","author":"Dresler","year":"2013","journal-title":"J.\u00a0Neural. Transm."},{"key":"10.1016\/j.jpsychires.2017.02.008_bib16","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/j.biopsych.2006.02.013","article-title":"A\u00a0neurotrophic model for stress-related mood disorders","volume":"59","author":"Duman","year":"2006","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jpsychires.2017.02.008_bib17","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/S0140-6736(00)02799-9","article-title":"Adverse drug reactions: definitions, diagnosis, and management","volume":"356","author":"Edwards","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.jpsychires.2017.02.008_bib18","series-title":"Summary of Product Characteristics","author":"European Medicines Agency","year":"2016"},{"key":"10.1016\/j.jpsychires.2017.02.008_bib19","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1176\/appi.ajp.2011.11071009","article-title":"Suicidal behavior and severe neuropsychiatric disorders following glucocorticoid therapy in primary care","volume":"169","author":"Fardet","year":"2012","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jpsychires.2017.02.008_bib20","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1017\/S1461145714000674","article-title":"The effects of methylphenidate on resting-state striatal., thalamic and global functional connectivity in healthy adults","volume":"17","author":"Farr","year":"2014","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.jpsychires.2017.02.008_bib21","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1007\/s40263-014-0192-0","article-title":"Pregabalin: a review of its use in adults with generalized anxiety disorder","volume":"28","author":"Frampton","year":"2014","journal-title":"CNS. Drugs"},{"key":"10.1016\/j.jpsychires.2017.02.008_bib22","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1176\/appi.ajp.157.4.493","article-title":"Neuroanatomical hypothesis of panic disorder, revised","volume":"157","author":"Gorman","year":"2000","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jpsychires.2017.02.008_bib23","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/j.biopsych.2005.10.015","article-title":"Antidepressant drug treatment modifies the neural processing of nonconscious threat cues","volume":"59","author":"Harmer","year":"2006","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jpsychires.2017.02.008_bib24","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/acps.12024","article-title":"Two-year course of anxiety disorders: different across disorders or dimensions?","volume":"128","author":"Hendriks","year":"2013","journal-title":"Acta. Psychiatr. Scand."},{"key":"10.1016\/j.jpsychires.2017.02.008_bib25","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1345\/aph.1Q387","article-title":"Panic attack induced by a single dose of prednisone","volume":"45","author":"Iskandar","year":"2011","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.jpsychires.2017.02.008_bib26","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1176\/appi.ajp.2014.13091264","article-title":"Adverse consequences of glucocorticoid medication: psychological, cognitive, and behavioral effects","volume":"171","author":"Judd","year":"2014","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jpsychires.2017.02.008_bib27","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1001\/archpsyc.63.4.415","article-title":"The epidemiology of panic attacks, panic disorder, and agoraphobia in the National Comorbidity Survey Replication","volume":"63","author":"Kessler","year":"2006","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.jpsychires.2017.02.008_bib28","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/2045-5380-2-20","article-title":"The role of the amygdala in the pathophysiology of panic disorder: evidence from neuroimaging studies","volume":"2","author":"Kim","year":"2012","journal-title":"Biol. Mood. Anxiety. Disord."},{"key":"10.1016\/j.jpsychires.2017.02.008_bib29","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.jpsychires.2012.09.013","article-title":"Changes in gray matter volume of remitted first-episode, drug-na\u00efve, panic disorder patients after 6-week antidepressant therapy","volume":"47","author":"Lai","year":"2013","journal-title":"J.\u00a0Psychiatr. Res."},{"key":"10.1016\/j.jpsychires.2017.02.008_bib30","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.pnpbp.2013.01.020","article-title":"Decreased GABA levels in anterior cingulate cortex\/medial prefrontal cortex in panic disorder","volume":"44","author":"Long","year":"2013","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.jpsychires.2017.02.008_bib31","doi-asserted-by":"crossref","first-page":"222","DOI":"10.5498\/wjp.v5.i2.222","article-title":"Inter-relationships between isotretinoin treatment and psychiatric disorders: depression, bipolar disorder, anxiety, psychosis and suicide risks","volume":"5","author":"Ludot","year":"2015","journal-title":"World. J. Psychiatry"},{"key":"10.1016\/j.jpsychires.2017.02.008_bib32","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/ajmg.c.30172","article-title":"Recent advances in the neurobiology of anxiety disorders: implications for novel therapeutics","volume":"148","author":"Mathew","year":"2008","journal-title":"Am. J. Med. Genet. C. Semin. Med. Genet."},{"key":"10.1016\/j.jpsychires.2017.02.008_bib33","doi-asserted-by":"crossref","first-page":"203","DOI":"10.2165\/00002018-200427030-00005","article-title":"The risk of severe depression, psychosis or panic attacks with prophylactic antimalarials","volume":"27","author":"Meier","year":"2004","journal-title":"Drug. Saf."},{"key":"10.1016\/j.jpsychires.2017.02.008_bib34","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0301-0082(03)00087-X","article-title":"The neurobiology and control of anxious states","volume":"70","author":"Millan","year":"2003","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.jpsychires.2017.02.008_bib35","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.therap.2016.02.010","article-title":"Causality assessment in pharmacovigilance: the French method and its successive updates","volume":"71","author":"Miremont-Salam\u00e9","year":"2016","journal-title":"Therapie"},{"key":"10.1016\/j.jpsychires.2017.02.008_bib36","first-page":"557","article-title":"[French pharmacovigilance database system: examples of utilisation]","volume":"50","author":"Moore","year":"1995","journal-title":"Therapie"},{"key":"10.1016\/j.jpsychires.2017.02.008_bib37","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/1440-1681.12538","article-title":"Neuroprotective effects of various doses of topiramate against methylphenidate induced oxidative stress and inflammation in rat isolated hippocampus","volume":"43","author":"Motaghinejad","year":"2016","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.jpsychires.2017.02.008_bib38","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.brainresbull.2014.09.011","article-title":"Dorsomedial hypothalamus serotonin 1A receptors mediate a panic-related response in the elevated T-maze","volume":"109","author":"Nascimento","year":"2014","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.jpsychires.2017.02.008_bib39","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1192\/bjp.bp.107.041186","article-title":"Serotonin 5-HT1A receptor binding in people with panic disorder: positron emission tomography study","volume":"193","author":"Nash","year":"2008","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.jpsychires.2017.02.008_bib40","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1523\/JNEUROSCI.4921-03.2004","article-title":"Reduced serotonin type 1A receptor binding in panic disorder","volume":"24","author":"Neumeister","year":"2004","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.jpsychires.2017.02.008_bib41","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1002\/hup.2349","article-title":"Advances in the neuroimaging of panic disorder","volume":"28","author":"Pannekoek","year":"2013","journal-title":"Hum. Psychopharmacol."},{"key":"10.1016\/j.jpsychires.2017.02.008_bib42","first-page":"69","article-title":"Panic attacks as a consequence of chronic corticosteroid therapy?","volume":"2","author":"Per\u00e9nyi","year":"1988","journal-title":"Eur. J. Psychiatry"},{"key":"10.1016\/j.jpsychires.2017.02.008_bib43","first-page":"1565","article-title":"Panic attacks in a patient treated with isotretinoin for acne. Report of one case","volume":"134","author":"Poblete","year":"2006","journal-title":"Rev. Med. Chil."},{"key":"10.1016\/j.jpsychires.2017.02.008_bib44","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/368064","article-title":"Complex membrane channel blockade: a unifying hypothesis for the prodromal and acute neuropsychiatric sequelae resulting from exposure to the antimalarial drug mefloquine","author":"Quinn","year":"2015","journal-title":"J.\u00a0Parasitol. Res."},{"key":"10.1016\/j.jpsychires.2017.02.008_bib45","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1097\/00005053-197207000-00008","article-title":"Pseudotumor cerebri, psychosis, and hypervitaminosis A","volume":"155","author":"Restak","year":"1972","journal-title":"J.\u00a0Nerv. Ment. Dis."},{"key":"10.1016\/j.jpsychires.2017.02.008_bib46","first-page":"224","article-title":"Psychiatric side effects of mefloquine: applications to forensic psychiatry","volume":"41","author":"Ritchie","year":"2013","journal-title":"J.\u00a0Am. Acad. Psychiatry Law"},{"key":"10.1016\/j.jpsychires.2017.02.008_bib47","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/S0140-6736(06)69418-X","article-title":"Panic disorder","volume":"368","author":"Roy-Byrne","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.jpsychires.2017.02.008_bib48","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.tmaid.2013.02.008","article-title":"Antimalarial chemoprophylaxis and the risk of neuropsychiatric disorders","volume":"11","author":"Schneider","year":"2013","journal-title":"Travel. Med. Infect. Dis."},{"key":"10.1016\/j.jpsychires.2017.02.008_bib49","doi-asserted-by":"crossref","first-page":"34","DOI":"10.4088\/JCP.v66n0105","article-title":"Efficacy and tolerability of controlled-release paroxetine in the treatment of panic disorder","volume":"66","author":"Sheehan","year":"2005","journal-title":"J.\u00a0Clin. Psychiatry"},{"key":"10.1016\/j.jpsychires.2017.02.008_bib50","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.jpsychires.2004.01.004","article-title":"Changes in anxiety sensitivity with pharmacotherapy for panic disorder","volume":"38","author":"Simon","year":"2004","journal-title":"J.\u00a0Psychiatr. Res."},{"key":"10.1016\/j.jpsychires.2017.02.008_bib51","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0165-0327(98)00221-3","article-title":"Mechanism of action of serotonin selective reuptake inhibitors. Serotonin receptors and pathways mediate therapeutic effects and side effects","volume":"51","author":"Stahl","year":"1998","journal-title":"J.\u00a0Affect. Disord."},{"key":"10.1016\/j.jpsychires.2017.02.008_bib52","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1111\/j.1365-4632.2006.02660.x","article-title":"Isotretinoin and the controversy of psychiatric adverse effects","volume":"45","author":"Strahan","year":"2006","journal-title":"Int. J. Dermatol"},{"key":"10.1016\/j.jpsychires.2017.02.008_bib53","series-title":"Martindale the Complete Drug Reference","author":"Sweetman","year":"2011"},{"key":"10.1016\/j.jpsychires.2017.02.008_bib54","doi-asserted-by":"crossref","first-page":"731","DOI":"10.2165\/00002018-200528080-00007","article-title":"Trends in spontaneous adverse drug reaction reports to the French pharmacovigilance system (1986-2001)","volume":"28","author":"Thiessard","year":"2005","journal-title":"Drug. Saf."},{"key":"10.1016\/j.jpsychires.2017.02.008_bib55","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.therap.2016.02.029","article-title":"French pharmacovigilance: missions, organization and perspectives","volume":"71","author":"Vial","year":"2016","journal-title":"Therapie"},{"key":"10.1016\/j.jpsychires.2017.02.008_bib56","series-title":"Advances in Inflammation Research","first-page":"1","article-title":"Epidemiology of adverse reactions to nonsteroidal antiinflammatory drugs","author":"Weber","year":"1984"},{"key":"10.1016\/j.jpsychires.2017.02.008_bib57","first-page":"95","article-title":"Phenomenology and epidemiology of panic disorder","volume":"21","author":"Yates","year":"2009","journal-title":"Ann. Clin. Psychiatry"}],"container-title":["Journal of Psychiatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395617301619?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395617301619?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,15]],"date-time":"2025-06-15T05:19:06Z","timestamp":1749964746000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022395617301619"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":57,"alternative-id":["S0022395617301619"],"URL":"https:\/\/doi.org\/10.1016\/j.jpsychires.2017.02.008","relation":{},"ISSN":["0022-3956"],"issn-type":[{"value":"0022-3956","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Drug-induced panic attacks: Analysis of cases registered in the French pharmacovigilance database","name":"articletitle","label":"Article Title"},{"value":"Journal of Psychiatric Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpsychires.2017.02.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}